{"transactions":[{"id":4614486,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-10T19:47:28.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":358,"price":1.1584,"value":414.7072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":126133,"source":{"system":"sec-edgar","filing":"0001193125-26-387816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312526387816/ownership.xml","form_type":"4"}},{"id":743386,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-10T15:19:56.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":558,"price":1.299,"value":724.842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares acquired under the Company's employee stock purchase plan (\"ESPP\") on May 29, 2026."}],"balance_after":126491,"source":{"system":"sec-edgar","filing":"0001193125-26-265326","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312526265326/ownership.xml","form_type":"4"}},{"id":816999,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T18:00:49.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":68000,"derivative":{"exercise_price":1.34,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001193125-26-141914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312526141914/ownership.xml","form_type":"4"}},{"id":816998,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-03T18:00:49.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":125549,"source":{"system":"sec-edgar","filing":"0001193125-26-141914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312526141914/ownership.xml","form_type":"4"}},{"id":853856,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-09T21:16:17.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":482,"price":1.6,"value":771.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":114549,"source":{"system":"sec-edgar","filing":"0001193125-26-098821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312526098821/ownership.xml","form_type":"4"}},{"id":977832,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-08T18:51:33.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":199,"price":1.7719,"value":352.6081,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":115031,"source":{"system":"sec-edgar","filing":"0001193125-25-310958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312525310958/ownership.xml","form_type":"4"}},{"id":985271,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-01T23:37:12.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":1.6,"value":153600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":115230,"source":{"system":"sec-edgar","filing":"0001193125-25-304177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312525304177/ownership.xml","form_type":"4"}},{"id":985270,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-01T23:37:12.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":199,"price":1.81,"value":360.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units (\"RSUs\") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,359 shares acquired under the Company's employee stock purchase plan (\"ESPP\") on May 30, 2025 and 1,377 shares acquired under the Company's ESPP on November 28, 2025."}],"balance_after":19230,"source":{"system":"sec-edgar","filing":"0001193125-25-304177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000119312525304177/ownership.xml","form_type":"4"}},{"id":1118281,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-09T23:04:41.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":199,"price":1.75,"value":348.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."}],"balance_after":16693,"source":{"system":"sec-edgar","filing":"0000950170-25-083963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017025083963/ownership.xml","form_type":"4"}},{"id":1180223,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T15:57:30.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":22725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":22725,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":22725},"source":{"system":"sec-edgar","filing":"0000950170-25-050100","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017025050100/ownership.xml","form_type":"4"}},{"id":1180222,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T15:57:30.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":21875,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0000950170-25-050100","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017025050100/ownership.xml","form_type":"4"}},{"id":1180221,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-03T15:57:30.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":3775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on March 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":16892,"source":{"system":"sec-edgar","filing":"0000950170-25-050100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017025050100/ownership.xml","form_type":"4"}},{"id":1180220,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-03T15:57:30.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":13117,"source":{"system":"sec-edgar","filing":"0000950170-25-050100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017025050100/ownership.xml","form_type":"4"}},{"id":1217772,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-07T21:38:13.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":930,"price":1.8748,"value":1743.564,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.85 to $1.90, inclusive. The reporting person undertakes to provide to Metagenomi, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":9467,"source":{"system":"sec-edgar","filing":"0000950170-25-035566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017025035566/ownership.xml","form_type":"4"}},{"id":1550514,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:57:27.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":43717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on February 1, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":43717,"derivative":{"exercise_price":10.82,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":43717},"source":{"system":"sec-edgar","filing":"0000950170-24-041545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017024041545/ownership.xml","form_type":"4"}},{"id":1550513,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39723,"kind":"person","name":"Wein Matthew","position":1,"cik":"0002009713","reported_name":"Wein Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-04T00:57:27.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":10397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on March 5, 2025, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":10397,"source":{"system":"sec-edgar","filing":"0000950170-24-041545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009713/000095017024041545/ownership.xml","form_type":"4"}}]}